Premium
Surgical risk in patients with cirrhosis
Author(s) -
Nicoll Amanda
Publication year - 2012
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2012.07205.x
Subject(s) - medicine , ascites , cirrhosis , spontaneous bacterial peritonitis , sepsis , hepatic encephalopathy , hepatorenal syndrome , portal hypertension , liver disease , surgery , model for end stage liver disease , stage (stratigraphy) , disease , peritonitis , chronic liver disease , intensive care medicine , liver transplantation , transplantation , paleontology , biology
Surgery in the patient with cirrhosis is problematic, as encephalopathy, ascites, sepsis and bleeding are common in the postoperative period. Accurate preoperative assessment and planning, and careful postoperative management have the potential to reduce the frequency and severity of such complications, and reduce the length of hospital stay, but there is little literature evidence to prove this. Operative mortality and other risks correlate with the severity of the liver disease, co‐morbidities and the type of surgery. The Child‐Turcott‐Pugh (CTP) score or model for end‐stage liver disease (MELD) score may be used to determine the severity of the liver disease, but must also take into account recent changes in the patient's condition. Surgery that does not involve opening the peritoneum may have slightly better outcomes, as the risk of ascitic leak, sepsis and difficult fluid management are reduced. Mortality rates range from 10% in CTP‐A patients to 82% in CTP‐C patients. The presence of portal hypertension is an important negative predictor, especially in abdominal surgery, as refractory ascites may occur. Careful monitoring in the postoperative period and early intervention of complications are essential. Hepatic resections in cirrhosis are associated with other considerations such as leaving sufficient liver tissue to prevent liver failure, and are beyond the scope of this review.